There are no approved pharmacological approaches that target the social impairments in autism spectrum disorder (ASD).
Autism spectrum disorder (ASD) is the fastest-growing developmental disorder in the United States. According to the Centers for Disease Control, one in 68 children is living with an ASD, with associated costs estimated at between $12 billion and $61 billion.ASD can impair empathy, the ability to share and understand the feelings of others, which is aided by the ability to read facial expression, tone of voice and other social cues.
‘Empathy-like behavior was induced by researchers by identifying then manipulating a brain circuit in an experimental model. This suggests that new strategies may help people with autism spectrum disorder gain social abilities.’
There are no approved pharmacological
approaches that target the social impairments in ASD. The development of
new approaches requires a better understanding of the neural changes
that cause the main symptoms of ASD. This study is a major step toward
that goal.
Researchers at Rosalind Franklin University of Medicine and Science have induced empathy-like behavior by identifying then manipulating a brain circuit in an experimental model, an indication that new strategies may help people with autism spectrum disorder (ASD) gain social abilities.
The study, led by Chicago Medical School Professor Amiel Rosenkranz, Department of Cellular and Molecular Pharmacology, sheds light on the specific role of the amygdala, an often overlooked brain region, in social behavior and its pathology in autism.
Published in the journal Nature Neuroscience, the findings change the conceptualization of the brain regions important in empathy and provide the rationale to target the amygdala in certain forms of ASD.
Investigators measured the empathy-like responses of a rodent while witnessing an "actor" rodent respond to a mild "startle." The "witness" quickly developed behaviors that matched the startled subject, reflecting a behavior that is a foundation for empathy. In addition, the witness learned that the emotional cues produced by the actor indicate that something in the environment may be dangerous.
Advertisement
To gain insight into the relevance of these findings for ASD, the study then examined impaired empathy caused by experimental deletion of Nrxn1, an analog of a human autism-associated gene (NRXN). Deletion of Nrxn1 was associated with a lack of empathy-like behavior in the witness, which investigators found to be correlated with poor neuronal function in the LA-MeA circuit.
Advertisement
Source-Eurekalert